How large is the brachytherapy treatment planning systems market?

The market revenue for brachytherapy treatment planning systems is anticipated at USD 1.13 billion in 2027.

How will the brachytherapy treatment planning systems industry grow in terms of size and CAGR by 2036?

Brachytherapy Treatment Planning Systems Market size stood at USD 1.05 billion in 2026 and is predicted to grow at a 9.03% CAGR from 2027 to 2036, exceeding USD 2.49 billion by 2036.

How is the shift toward advanced 3D imaging techniques reshaping clinical decision-making in brachytherapy treatment planning systems?

3D Image Reconstruction is improving anatomical visualization and spatial accuracy in complex implant cases, enabling clinicians to build more precise, individualized treatment plans. This enhances confidence in dose placement and supports more refined planning decisions beyond conventional imaging workflows.

Why are AI-enabled contouring and imaging automation becoming central to workflow efficiency in brachytherapy planning?

Auto-contouring and related software reduce manual effort in delineating targets and organs at risk, improving consistency and speeding up planning cycles. This allows oncology teams to standardize workflows and manage higher patient volumes with more reliable treatment preparation.

Why is in-room imaging the leading technique in the brachytherapy treatment planning systems market?

In-room imaging accounted for 57.96% of the market in 2026 because it enables real-time image acquisition, supports accurate applicator placement, and improves treatment planning efficiency during procedures.

Why is PET/CT deformable software the fastest-growing component in the brachytherapy treatment planning systems market?

PET/CT deformable software is growing rapidly because it improves image fusion and anatomical alignment across datasets, supporting more accurate planning for complex multimodal treatment workflows.

What makes North America the leading market for brachytherapy treatment planning systems?

North America leads the market through established radiation oncology infrastructure, widespread use of advanced planning software, and strong demand for precise, image-guided brachytherapy workflows in cancer care.

Why is Asia Pacific the fastest-growing regional market for brachytherapy treatment planning systems?

Asia Pacific is expected to grow at a 10.85% CAGR as hospitals expand oncology services, invest in modern radiotherapy technologies, and adopt software-driven treatment planning for higher patient volumes.

Who holds a significant market share in the brachytherapy treatment planning systems landscape?

Leading players in the brachytherapy treatment planning systems market include Elekta AB (Sweden), Varian Medical Systems, Inc. (United States), RaySearch Laboratories AB (Sweden), MIM Software Inc. (United States), Prowess, Inc. (United States), Eckert & Ziegler BEBIG GmbH (Germany), CIVCO Medical Solutions (United States), Philips Healthcare (Netherlands), Siemens Healthineers AG (Germany), Accuray Incorporated (United States).